Gene: NR2E1

7101
TLL|TLX|XTLL
nuclear receptor subfamily 2 group E member 1
protein-coding
6q21
Ensembl:ENSG00000112333 MIM:603849 Vega:OTTHUMG00000015319 UniprotKB:Q9Y466
NG_042807.1
PubMed
ND
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
2.361e-1 (AD)  8.072e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
EZR0.905
STOX10.897
ARHGEF260.893
SLC1A30.892
OAF0.886
SLC4A40.884
EMX20.883
FAM167A0.879
TP53BP20.878
CLDN100.875

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
NRG1-0.466
ADTRP-0.448
TRABD2A-0.436
THEMIS-0.433
FOXP2-0.432
ENPP6-0.43
NPFFR2-0.426
QRFPR-0.425
POSTN-0.422
SAMD5-0.415

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2E1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2E1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2E1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2E1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2E1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2E1 mRNA"27188386
D000082AcetaminophenAcetaminophen affects the expression of NR2E1 mRNA25064622
D000638AmiodaroneAmiodarone affects the expression of NR2E1 mRNA25064622
D001151ArsenicArsenic affects the methylation of NR2E1 gene25304211
C015001arsenitearsenite results in increased methylation of NR2E1 promoter23974009
C006780bisphenol Abisphenol A affects the methylation of NR2E1 promoter27334623
C006780bisphenol Abisphenol A results in decreased expression of NR2E1 mRNA25181051
D002746ChlorpromazineChlorpromazine affects the expression of NR2E1 mRNA25064622
D019327Copper SulfateCopper Sulfate results in increased expression of NR2E1 mRNA19549813
D016572CyclosporineCyclosporine affects the expression of NR2E1 mRNA25064622
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of NR2E1 mRNA25064622
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of NR2E1 mRNA28001369
D010269ParaquatParaquat affects the expression of NR2E1 mRNA25064622
D012822Silicon DioxideSilicon Dioxide analog results in increased expression of NR2E1 mRNA25895662
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of NR2E1 mRNA21570461|2405805
D013752TetracyclineTetracycline affects the expression of NR2E1 mRNA25064622
D013853ThioacetamideThioacetamide affects the expression of NR2E1 mRNA25064622
C012589trichostatin Atrichostatin A results in decreased expression of NR2E1 mRNA15901671
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2E1 mRNA"27188386
C012589trichostatin Atrichostatin A results in decreased expression of NR2E1 mRNA24935251|2627250
D014635Valproic AcidValproic Acid affects the expression of NR2E1 mRNA25064622
D014635Valproic AcidValproic Acid results in decreased expression of NR2E1 mRNA15901671
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2E1 mRNA"27188386
D014635Valproic AcidValproic Acid results in decreased expression of NR2E1 mRNA23179753|2438349
D014635Valproic AcidValproic Acid results in increased expression of NR2E1 mRNA19101580|2317975
D001335Vehicle EmissionsVehicle Emissions results in increased methylation of NR2E1 gene25560391
C111237vorinostat"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2E1 mRNA"27188386
C111237vorinostatvorinostat results in decreased expression of NR2E1 mRNA26272509

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0000981RNA polymerase II transcription factor activity, sequence-specific DNA binding-ISA-  
GO:0000981RNA polymerase II transcription factor activity, sequence-specific DNA binding-ISM19274049  
GO:0000981RNA polymerase II transcription factor activity, sequence-specific DNA binding-NAS19274049  
GO:0001077transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding-IEA-  
GO:0001078transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding-IEA-  
GO:0003707steroid hormone receptor activity-IEA-  
GO:0005515protein binding-IPI28420882  
GO:0008270zinc ion binding-IEA-  
GO:0042826histone deacetylase binding-IEA-  
GO:0043565sequence-specific DNA binding-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0000122negative regulation of transcription by RNA polymerase II-IEA-  
GO:0001662behavioral fear response-IEA-  
GO:0002118aggressive behavior-IEA-  
GO:0006367transcription initiation from RNA polymerase II promoter-TAS-  
GO:0007399nervous system development-TAS9628820  
GO:0007601visual perception-IEA-  
GO:0021542dentate gyrus development-IEA-  
GO:0021764amygdala development-IEA-  
GO:0021772olfactory bulb development-IEA-  
GO:0021819layer formation in cerebral cortex-IEA-  
GO:0021872forebrain generation of neurons-IEA-  
GO:0021895cerebral cortex neuron differentiation-IEA-  
GO:0021960anterior commissure morphogenesis-IEA-  
GO:0030198extracellular matrix organization-IEA-  
GO:0035019somatic stem cell population maintenance-IEA-  
GO:0035176social behavior-IEA-  
GO:0043066negative regulation of apoptotic process-IEA-  
GO:0043401steroid hormone mediated signaling pathway-IEA-  
GO:0045165cell fate commitment-IEA-  
GO:0045665negative regulation of neuron differentiation-IEA-  
GO:0045766positive regulation of angiogenesis-IEA-  
GO:0045787positive regulation of cell cycle-IEA-  
GO:0045944positive regulation of transcription by RNA polymerase II-IEA-  
GO:0048712negative regulation of astrocyte differentiation-IEA-  
GO:0048814regulation of dendrite morphogenesis-IEA-  
GO:0060041retina development in camera-type eye-IEA-  
GO:0060164regulation of timing of neuron differentiation-IEA-  
GO:0060291long-term synaptic potentiation-IEA-  
GO:0090049regulation of cell migration involved in sprouting angiogenesis-IEA-  
GO:2000178negative regulation of neural precursor cell proliferation-IEA-  
GO:2000179positive regulation of neural precursor cell proliferation-IEA-  
GO:2000648positive regulation of stem cell proliferation-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005654nucleoplasm-TAS-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-1257604PIP3 activates AKT signalingIEA
R-HSA-162582Signal TransductionIEA
R-HSA-212436Generic Transcription PathwayTAS
R-HSA-383280Nuclear Receptor transcription pathwayTAS
R-HSA-6807070PTEN RegulationIEA
R-HSA-73857RNA Polymerase II TranscriptionTAS
R-HSA-74160Gene expression (Transcription)TAS
R-HSA-8943724Regulation of PTEN gene transcriptionIEA
R-HSA-9006925Intracellular signaling by second messengersIEA

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
24847019In utero exposure to cigarette smoke dysregulates human fetal ovarian developmental signalling. (2014 Jul)Fowler PAHum Reprod